Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
Public ClinicalTrials.gov record NCT02996435. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
smartADHERE - Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
Study identification
- NCT ID
- NCT02996435
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Janssen Scientific Affairs, LLC
- Industry
- Enrollment
- 139 participants
Conditions and interventions
Conditions
Interventions
- Mobile Application Intervention Behavioral
- No Intervention Other
Behavioral · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 20, 2016
- Primary completion
- Mar 21, 2018
- Completion
- Mar 21, 2018
- Last update posted
- Oct 25, 2018
2016 – 2018
United States locations
- U.S. sites
- 25
- U.S. states
- 13
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anchorage | Alaska | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Manhattan Beach | California | — | — |
| Not listed | Oakland | California | — | — |
| Not listed | Pasadena | California | — | — |
| Not listed | Stanford | California | — | — |
| Not listed | Ventura | California | — | — |
| Not listed | Pensacola | Florida | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Saint Joseph | Michigan | — | — |
| Not listed | Reno | Nevada | — | — |
| Not listed | Buffalo | New York | — | — |
| Not listed | Jamaica | New York | — | — |
| Not listed | Lake Success | New York | — | — |
| Not listed | Mineola | New York | — | — |
| Not listed | Saratoga Springs | New York | — | — |
| Not listed | Canton | Ohio | — | — |
| Not listed | Doylestown | Pennsylvania | — | — |
| Not listed | Reading | Pennsylvania | — | — |
| Not listed | Yardley | Pennsylvania | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Bellevue | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02996435, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02996435 live on ClinicalTrials.gov.